Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers?
-
Correspondence: Fredrik Wiklund ross.hopkins@biomedcentral.com
Genome Med 2010, 2:45 doi:10.1186/gm166
Accesses
- Last 30 days: 65 accesses
- Last 365 days: 886 accesses
- All time: 1821 accesses